Patents by Inventor Suketu Sanghvi

Suketu Sanghvi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20240156787
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: January 24, 2024
    Publication date: May 16, 2024
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • EPINEPHRINE FORMULATIONS
    Publication number: 20240091176
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: September 19, 2023
    Publication date: March 21, 2024
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • EPINEPHRINE FORMULATIONS
    Publication number: 20240058281
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: September 28, 2023
    Publication date: February 22, 2024
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • Losartan liquid formulations and methods of use
    Patent number: 11890273
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Grant
    Filed: November 2, 2022
    Date of Patent: February 6, 2024
    Assignee: SCIENTURE, INC.
    Inventors: Bhavya Teja Kolla, Rahul Surana, Suketu Sanghvi, Jigar Bhatt
  • LONG-ACTING BUPIVACAINE MICROSPHERE FORMULATIONS
    Publication number: 20240033221
    Abstract: According to various aspects of this disclosure, the present disclosure relates to long-acting, shelf-stable microsphere formulations of bupivacaine, kits, and methods for treating or preventing pain by parenteral injection of a microsphere formulation of bupivacaine.
    Type: Application
    Filed: April 22, 2021
    Publication date: February 1, 2024
    Inventors: Shankar HARIHARAN, Suketu SANGHVI, Rahul SURANA, Maarten van DIJK, Ivan TERZIC, Kimberly Aniek BANUS, Thanh NGUYEN, Rob STEENDAM
  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20230414574
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: December 5, 2022
    Publication date: December 28, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20230256048
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: July 11, 2022
    Publication date: August 17, 2023
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • LOSARTAN LIQUID FORMULATIONS AND METHODS OF USE
    Publication number: 20230218582
    Abstract: The present disclosure relates to stable, liquid pharmaceutical compositions of losartan or pharmaceutically acceptable salts thereof for oral administration. The present disclosure further provides powder compositions for reconstitution to provide a liquid formulation. In further aspects, the present disclosure relates to processes for preparation of such pharmaceutical compositions, and methods of treating a subject in need of losartan by administration of a formulation described herein.
    Type: Application
    Filed: November 2, 2022
    Publication date: July 13, 2023
    Inventors: Bhavya Teja KOLLA, Rahul SURANA, Suketu SANGHVI, Jigar BHATT
  • LONG-ACTING APOMORPHINE FORMULATIONS AND INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
    Publication number: 20230137010
    Abstract: The present disclosure is directed to formulations, devices, kits, and methods for treating or preventing motor symptoms associated with Parkinson's disease by injection of a microsphere formulation of apomorphine free base or a pharmaceutically acceptable a salt thereof, wherein injection can be from a pre-filled injector.
    Type: Application
    Filed: April 12, 2021
    Publication date: May 4, 2023
    Inventors: Shankar HARIHARAN, Suketu SANGHVI, Suneel GUPTA, Rahul SURANA, Ivan TERZIC, Albert DOORNBOS, Rob STEENDAM
  • EPINEPHRINE FORMULATIONS
    Publication number: 20230100523
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: March 2, 2022
    Publication date: March 30, 2023
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • DIHYDROERGOTAMINE MESYLATE FORMULATIONS AND PRE-FILLED INJECTORS FOR THERAPEUTIC DELIVERY OF THE SAME
    Publication number: 20230043204
    Abstract: The present disclosure is directed to formulations and methods for treating or preventing head pain, including migraines, with dihydroergotamine mesylate.
    Type: Application
    Filed: December 21, 2020
    Publication date: February 9, 2023
    Inventors: Shankar HARIHARAN, Bhavya Teja KOLLA, Suketu SANGHVI, Rahul SURANA
  • Epinephrine formulations
    Patent number: 11337938
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Grant
    Filed: March 12, 2020
    Date of Patent: May 24, 2022
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20220133838
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: September 10, 2021
    Publication date: May 5, 2022
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Vasopressin formulations for use in treatment of hypotension
    Patent number: 11207372
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: December 28, 2021
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Vasopressin formulations for use in treatment of hypotension
    Patent number: 11135265
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Grant
    Filed: March 4, 2019
    Date of Patent: October 5, 2021
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
    Publication number: 20210077568
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: November 25, 2020
    Publication date: March 18, 2021
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • EPINEPHRINE FORMULATIONS
    Publication number: 20200206163
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Application
    Filed: March 12, 2020
    Publication date: July 2, 2020
    Inventors: Suketu SANGHVI, Vinayagam KANNAN, Matthew KENNEY
  • PEPTIDE CONGENERS WITH POLYMER EXCIPIENTS
    Publication number: 20200188474
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: October 16, 2018
    Publication date: June 18, 2020
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi
  • Epinephrine formulations
    Patent number: 10624864
    Abstract: Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
    Type: Grant
    Filed: January 25, 2019
    Date of Patent: April 21, 2020
    Assignee: PAR PHARMACEUTICAL, INC.
    Inventors: Suketu Sanghvi, Vinayagam Kannan, Matthew Kenney
  • VASOPRESSIN FORMULATIONS FOR USE IN TREATMENT OF HYPOTENSION
    Publication number: 20190192615
    Abstract: Provided herein are peptide formulations comprising polymers as stabilizing agents. The peptide formulations can be more stable for prolonged periods of time at temperatures higher than room temperature when formulated with the polymers. The polymers used in the present invention can decrease the degradation of the constituent peptides of the peptide formulations.
    Type: Application
    Filed: March 4, 2019
    Publication date: June 27, 2019
    Inventors: Matthew Kenney, Vinayagam Kannan, Sunil Vandse, Suketu Sanghvi